Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy”

[1]  C. Landersdorfer,et al.  Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery. , 2020, ACS pharmacology & translational science.

[2]  Musa Hassan Muhammad,et al.  Beyond Risk: Bacterial Biofilms and Their Regulating Approaches , 2020, Frontiers in Microbiology.

[3]  R. A. Arthur,et al.  Spatial mapping of polymicrobial communities reveals a precise biogeography associated with human dental caries , 2020, Proceedings of the National Academy of Sciences.

[4]  J. Azzi,et al.  Boron doped silver-copper alloy nanoparticle targeting intracellular S. aureus in bone cells , 2020, PloS one.

[5]  C. Beck,et al.  Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitis. , 2020, European cells & materials.

[6]  E. Schwarz,et al.  A murine femoral ostectomy model with hardware exchange to assess antibiotic-impregnated spacers for implant-associated osteomyelitis. , 2019, European cells & materials.

[7]  S. Gill,et al.  An in vitro platform for elucidating the molecular genetics of S. aureus invasion of the osteocyte lacuno-canalicular network during chronic osteomyelitis. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[8]  R. O’Toole,et al.  2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  H. Rohde,et al.  2018 international consensus meeting on musculoskeletal infection: Summary from the biofilm workgroup and consensus on biofilm related musculoskeletal infections , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  N. Putnam,et al.  MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis , 2019, PLoS pathogens.

[11]  E. Schwarz,et al.  Evidence of differential microbiomes in healing versus non‐healing diabetic foot ulcers prior to and following foot salvage therapy , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  S. Kates,et al.  Calcium Phosphate Spacers for the Local Delivery of Sitafloxacin and Rifampin to Treat Orthopedic Infections: Efficacy and Proof of Concept in a Mouse Model of Single-Stage Revision of Device-Associated Osteomyelitis , 2019, Pharmaceutics.

[13]  J. Callaghan,et al.  Introduction: Proceedings of International Consensus on Orthopedic Infections. , 2019, The Journal of arthroplasty.

[14]  V. Migonney,et al.  Review of titanium surface modification techniques and coatings for antibacterial applications. , 2019, Acta biomaterialia.

[15]  S. Kates,et al.  A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants , 2018, mSphere.

[16]  Robin Patel,et al.  General Assembly, Prevention, Operating Room - Personnel: Proceedings of International Consensus on Orthopedic Infections , 2018, The Journal of Arthroplasty.

[17]  K. Asehnoune,et al.  Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial , 2018, Intensive Care Medicine.

[18]  S. Gill,et al.  Tracking Anti-Staphylococcus aureus Antibodies Produced In Vivo and Ex Vivo during Foot Salvage Therapy for Diabetic Foot Infections Reveals Prognostic Insights and Evidence of Diversified Humoral Immunity , 2018, Infection and Immunity.

[19]  E. Schwarz,et al.  Staphylococcus aureus Evasion of Host Immunity in the Setting of Prosthetic Joint Infection: Biofilm and Beyond , 2018, Current Reviews in Musculoskeletal Medicine.

[20]  C. Beck,et al.  Immunotherapy synergizes with debridement and antibiotic therapy in a murine 1‐stage exchange model of MRSA implant‐associated osteomyelitis , 2018, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[21]  S. Pederson,et al.  Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes , 2018, mBio.

[22]  W. J. Perry,et al.  Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions , 2018, Science Translational Medicine.

[23]  F. O'Brien,et al.  Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions , 2018, Clinical Microbiology Reviews.

[24]  S. Shivaswamy,et al.  A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia , 2018, PloS one.

[25]  C. Quave,et al.  Targeting Virulence in Staphylococcus aureus by Chemical Inhibition of the Accessory Gene Regulator System In Vivo , 2018, mSphere.

[26]  M. Roche,et al.  Season of the year influences infection rates following total hip arthroplasty , 2017, World journal of orthopedics.

[27]  D. Berry,et al.  Irrigation and Debridement with Component Retention for Acute Infection After Hip Arthroplasty: Improved Results with Contemporary Management , 2017, The Journal of bone and joint surgery. American volume.

[28]  A. Simpson,et al.  Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: A REVIEW OF COHORT STUDIES , 2017, The bone & joint journal.

[29]  E. Uribe-Querol,et al.  Control of Phagocytosis by Microbial Pathogens , 2017, Front. Immunol..

[30]  Fei Yang,et al.  The immobilization of antibiotic-loaded polymeric coatings on osteoarticular Ti implants for the prevention of bone infections. , 2017, Biomaterials science.

[31]  G. Schmidmaier,et al.  Clinical experiences in the use of a gentamicin-coated titanium nail in tibia fractures. , 2017, Injury.

[32]  J. Wenke,et al.  Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections. , 2017, Injury.

[33]  P. Sendi,et al.  The Classification of Long Bone Osteomyelitis: A Systemic Review of the Literature , 2017, Journal of bone and joint infection.

[34]  Raju Vaishya,et al.  Is Single-stage Revision Safe Following Infected Total Knee Arthroplasty? A Critical Review , 2017, Cureus.

[35]  Zhongtang Liu,et al.  Gentamicin coating of nanotubular anodized titanium implant reduces implant-related osteomyelitis and enhances bone biocompatibility in rabbits , 2017, International journal of nanomedicine.

[36]  S. Jain,et al.  Antibiotic laden bone cement in chronic osteomyelitis , 2017 .

[37]  D. Kelly,et al.  The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications , 2017, Front. Immunol..

[38]  T. Wood,et al.  Viable bacteria persist on antibiotic spacers following two‐stage revision for periprosthetic joint infection , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[39]  S. Kates,et al.  Evidence of Staphylococcus Aureus Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  R. Mansour,et al.  Chronic osteomyelitis of the pubic bones following radiotherapy for urological malignancy , 2017 .

[41]  T. Foster.  Antibiotic resistance in Staphylococcus aureus. Current status and future prospects , 2017, FEMS microbiology reviews.

[42]  H. Dym,et al.  Microbiology of Acute and Chronic Osteomyelitis and Antibiotic Treatment. , 2017, Dental clinics of North America.

[43]  S. Gill,et al.  Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence , 2017, Infection and Immunity.

[44]  Jeffrey D. Neighbors,et al.  Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms. , 2017, Journal of medicinal chemistry.

[45]  G. Ziółkowski,et al.  Bad to the Bone: On In Vitro and Ex Vivo Microbial Biofilm Ability to Directly Destroy Colonized Bone Surfaces without Participation of Host Immunity or Osteoclastogenesis , 2017, PloS one.

[46]  A. Yorukoglu,et al.  Fosfomycin Addition to Poly(D,L-Lactide) Coating Does Not Affect Prophylaxis Efficacy in Rat Implant-Related Infection Model, But That of Gentamicin Does , 2016, PloS one.

[47]  H. Jafri,et al.  Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults , 2016, Antimicrobial Agents and Chemotherapy.

[48]  R. G. Richards,et al.  Infection after fracture fixation: Current surgical and microbiological concepts. , 2016, Injury.

[49]  K. Ong,et al.  Risk of Reinfection After Treatment of Infected Total Knee Arthroplasty. , 2016, The Journal of arthroplasty.

[50]  K. Jandt,et al.  Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats. , 2016, Biomaterials.

[51]  W. Haggard,et al.  Antibiotic-loaded phosphatidylcholine inhibits staphylococcal bone infection. , 2016, World journal of orthopedics.

[52]  A. Hakansson,et al.  Directed vaccination against pneumococcal disease , 2016, Proceedings of the National Academy of Sciences.

[53]  B. Giersing,et al.  Status of vaccine research and development of vaccines for Staphylococcus aureus. , 2016, Vaccine.

[54]  M. Battegay,et al.  Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[55]  R. G. Richards,et al.  Orthopaedic device-related infection: current and future interventions for improved prevention and treatment , 2016, EFORT open reviews.

[56]  A. Simpson,et al.  Exchange nailing for nonunion of diaphyseal fractures of the tibia: our results and an analysis of the risk factors for failure. , 2016, The bone & joint journal.

[57]  Richard D Braatz,et al.  Designer Dual Therapy Nanolayered Implant Coatings Eradicate Biofilms and Accelerate Bone Tissue Repair. , 2016, ACS nano.

[58]  Jason A Inzana,et al.  Biomaterials approaches to treating implant-associated osteomyelitis. , 2016, Biomaterials.

[59]  Martin Müller,et al.  Testing of antibiotic releasing implant coatings to fight bacteria in combat-associated osteomyelitis – an in-vitro study , 2016, International Orthopaedics.

[60]  S. Fuchs-Winkelmann,et al.  Systemic antibiotic therapy does not significantly improve outcome in a rat model of implant-associated osteomyelitis induced by Methicillin susceptible Staphylococcus aureus , 2016, Archives of Orthopaedic and Trauma Surgery.

[61]  S. Nishio,et al.  The responses of macrophages in interaction with neutrophils that undergo NETosis. , 2016, Journal of autoimmunity.

[62]  Cynthia S Crowson,et al.  Prevalence of Total Hip and Knee Replacement in the United States. , 2015, The Journal of bone and joint surgery. American volume.

[63]  S. Kates,et al.  Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant‐associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[64]  D. Missiakas,et al.  Staphylococcal manipulation of host immune responses , 2015, Nature Reviews Microbiology.

[65]  D. Hak,et al.  Local antibiotic therapy strategies in orthopaedic trauma: Practical tips and tricks and review of the literature. , 2015, Injury.

[66]  K. Kleinschmidt,et al.  Mesenchymal stromal cell implantation for stimulation of long bone healing aggravates Staphylococcus aureus induced osteomyelitis. , 2015, Acta biomaterialia.

[67]  R. G. Richards,et al.  A doxycycline-loaded polymer-lipid encapsulation matrix coating for the prevention of implant-related osteomyelitis due to doxycycline-resistant methicillin-resistant Staphylococcus aureus. , 2015, Journal of Controlled Release.

[68]  A. Holmberg,et al.  75% success rate after open debridement, exchange of tibial insert, and antibiotics in knee prosthetic joint infections , 2015, Acta orthopaedica.

[69]  F. DeLeo,et al.  Pathogenesis of Staphylococcus aureus abscesses. , 2015, The American journal of pathology.

[70]  S. Lustig,et al.  Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[71]  C. Beck,et al.  A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis , 2015, Clinical orthopaedics and related research.

[72]  J. Suzich,et al.  MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model , 2015, Antimicrobial Agents and Chemotherapy.

[73]  D. Brabazon,et al.  Silver nanoparticles and their orthopaedic applications. , 2015, The bone & joint journal.

[74]  S. Fuchs-Winkelmann,et al.  Coating with a novel gentamicinpalmitate formulation prevents implant-associated osteomyelitis induced by methicillin-susceptible Staphylococcus aureus in a rat model , 2015, International Orthopaedics.

[75]  D. Suvà,et al.  Acute and chronic osteomyelitis , 2015, Schlossberg's Clinical Infectious Disease.

[76]  E. Chlebus,et al.  Microbial biofilms are able to destroy hydroxyapatite in the absence of host immunity in vitro. , 2015, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[77]  Jason A Inzana,et al.  A novel murine model of established Staphylococcal bone infection in the presence of a fracture fixation plate to study therapies utilizing antibiotic-laden spacers after revision surgery. , 2015, Bone.

[78]  Hong-chul Lim,et al.  The Parameters Affecting the Success of Irrigation and Debridement with Component Retention in the Treatment of Acutely Infected Total Knee Arthroplasty , 2015, Clinics in orthopedic surgery.

[79]  R. Grimer,et al.  Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. , 2015, The bone & joint journal.

[80]  F. Vandenesch,et al.  Antimicrobial Activity against Intraosteoblastic Staphylococcus aureus , 2015, Antimicrobial Agents and Chemotherapy.

[81]  D. Missiakas,et al.  Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus. , 2015, Vaccine.

[82]  K. Dutta,et al.  Mechanisms Mediating Enhanced Neutralization Efficacy of Staphylococcal Enterotoxin B by Combinations of Monoclonal Antibodies* , 2015, The Journal of Biological Chemistry.

[83]  Junhee Seok,et al.  Mice are not men , 2014, Proceedings of the National Academy of Sciences.

[84]  K. Wittrup,et al.  Five birds, one stone: Neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody , 2014, mAbs.

[85]  Eric Muraille,et al.  Th1/Th2 Paradigm Extended: Macrophage Polarization as an Unappreciated Pathogen-Driven Escape Mechanism? , 2014, Front. Immunol..

[86]  M. V. D. van den Bekerom,et al.  Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts. , 2014, World journal of orthopedics.

[87]  R. Schnettler,et al.  Intracellular proliferation of S. aureus in osteoblasts and effects of rifampicin and gentamicin on S. aureus intracellular proliferation and survival. , 2014, European cells & materials.

[88]  S. Kates,et al.  Passive immunization with anti‐glucosaminidase monoclonal antibodies protects mice from implant‐associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[89]  Herren Wu,et al.  Mechanisms of Neutralization of a Human Anti-α-toxin Antibody* , 2014, The Journal of Biological Chemistry.

[90]  S. Gurunathan,et al.  Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria , 2014, Nanoscale Research Letters.

[91]  Bingyun Li,et al.  Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection , 2014, BMC Microbiology.

[92]  P. Schlievert,et al.  Models matter: the search for an effective Staphylococcus aureus vaccine , 2014, Nature Reviews Microbiology.

[93]  H. Haider,et al.  Pulse lavage is inadequate at removal of biofilm from the surface of total knee arthroplasty materials. , 2014, The Journal of arthroplasty.

[94]  M. McNally,et al.  The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. , 2014, The bone & joint journal.

[95]  L. Drago,et al.  A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study. , 2014, The bone & joint journal.

[96]  V. Fowler,et al.  Where does a Staphylococcus aureus vaccine stand? , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[97]  S. Kates,et al.  A systematic review of animal models for Staphylococcus aureus osteomyelitis. , 2014, European cells & materials.

[98]  R. G. Richards,et al.  Propionibacterium acnes and Staphylococcus lugdunensis Cause Pyogenic Osteomyelitis in an Intramedullary Nail Model in Rabbits , 2014, Journal of Clinical Microbiology.

[99]  M. Otto.  Staphylococcus aureus toxins. , 2014, Current opinion in microbiology.

[100]  Timothy J. Foster,et al.  Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus , 2013, Nature Reviews Microbiology.

[101]  S. Kurtz,et al.  Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision , 2013, Knee Surgery, Sports Traumatology, Arthroscopy.

[102]  S. Kates,et al.  Anti-glucosaminidase IgG in sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients. , 2013, The Journal of bone and joint surgery. American volume.

[103]  Susmita Bose,et al.  SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo. , 2013, Acta biomaterialia.

[104]  G. Schultz,et al.  Antimicrobial dressing efficacy against mature Pseudomonas aeruginosa biofilm on porcine skin explants , 2013, International wound journal.

[105]  M. Mawatari,et al.  Silver oxide‐containing hydroxyapatite coating has in vivo antibacterial activity in the rat tibia , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[106]  E. Peters,et al.  Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention) , 2013, Acta orthopaedica.

[107]  T. Hamza,et al.  Intra-cellular Staphylococcus aureus alone causes infection in vivo. , 2013, European cells & materials.

[108]  I. Parkin,et al.  A novel bone cement impregnated with silver–tiopronin nanoparticles: its antimicrobial, cytotoxic, and mechanical properties , 2013, International journal of nanomedicine.

[109]  Shuilin Wu,et al.  Synthesis of silver-incorporated hydroxyapatite nanocomposites for antimicrobial implant coatings , 2013 .

[110]  R. Betts,et al.  Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. , 2013, JAMA.

[111]  Brendan F Gilmore,et al.  Clinical relevance of the ESKAPE pathogens , 2013, Expert review of anti-infective therapy.

[112]  A. Zecconi,et al.  Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. , 2013, Immunology letters.

[113]  I. Chopra,et al.  Staphylococcus aureus Biofilms Promote Horizontal Transfer of Antibiotic Resistance , 2013, Antimicrobial Agents and Chemotherapy.

[114]  Brian R Wolf,et al.  Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. , 2012, JAMA.

[115]  Heather N. Watson,et al.  Economic burden of periprosthetic joint infection in the United States. , 2012, The Journal of arthroplasty.

[116]  M. Asaduzzaman,et al.  Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo , 2012, Nature Medicine.

[117]  J. Parvizi,et al.  Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study. , 2012, The Journal of bone and joint surgery. American volume.

[118]  Shelain Patel,et al.  Aggressive Early Débridement for Treatment of Acutely Infected Cemented Total Hip Arthroplasty , 2012, Clinical orthopaedics and related research.

[119]  L. Zeitlin,et al.  Synthetic Human Monoclonal Antibodies toward Staphylococcal Enterotoxin B (SEB) Protective against Toxic Shock Syndrome* , 2012, The Journal of Biological Chemistry.

[120]  Gordon Y C Cheung,et al.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections , 2012, Expert opinion on therapeutic targets.

[121]  M. Fraunholz,et al.  Intracellular staphylococcus aureus: Live-in and let die , 2012, Front. Cell. Inf. Microbio..

[122]  R. Proctor.  Challenges for a universal Staphylococcus aureus vaccine. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  R. Hoffmann,et al.  Treatment algorithms for chronic osteomyelitis. , 2012, Deutsches Arzteblatt international.

[124]  J. Smolen,et al.  Inflammatory bone loss: pathogenesis and therapeutic intervention , 2012, Nature Reviews Drug Discovery.

[125]  S. Bertholet,et al.  Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials , 2012, Front. Cell. Inf. Microbio..

[126]  D. Libraty,et al.  Staphylococcus aureus reactivation osteomyelitis after 75 years. , 2012, The New England journal of medicine.

[127]  D. Missiakas,et al.  Recurrent infections and immune evasion strategies of Staphylococcus aureus. , 2012, Current opinion in microbiology.

[128]  S. Periasamy,et al.  How Staphylococcus aureus biofilms develop their characteristic structure , 2012, Proceedings of the National Academy of Sciences.

[129]  R. Barth,et al.  'To bead or not to bead?' Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. , 2011, International journal of antimicrobial agents.

[130]  Alessandro Bistolfi,et al.  Antibiotic-Loaded Cement in Orthopedic Surgery: A Review , 2011, ISRN orthopedics.

[131]  T. Guda,et al.  Dual-Purpose Bone Grafts Improve Healing and Reduce Infection , 2011, Journal of orthopaedic trauma.

[132]  Xiao-Kui Guo,et al.  The effect of Staphylococcus aureus on apoptosis of cultured human osteoblasts , 2011, Orthopaedic surgery.

[133]  M. Trautman,et al.  A Randomized Study of a Monoclonal Antibody (Pagibaximab) to Prevent Staphylococcal Sepsis , 2011, Pediatrics.

[134]  Joseph C Wenke,et al.  Effect of various concentrations of antibiotics on osteogenic cell viability and activity , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[135]  Kenneth W. Bayles,et al.  Staphylococcus aureus Biofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation In Vivo , 2011, The Journal of Immunology.

[136]  D. Missiakas,et al.  A play in four acts: Staphylococcus aureus abscess formation. , 2011, Trends in microbiology.

[137]  E. Walsh,et al.  Circulating Human Antibody-Secreting Cells during Vaccinations and Respiratory Viral Infections Are Characterized by High Specificity and Lack of Bystander Effect , 2011, The Journal of Immunology.

[138]  E. Schwarz,et al.  Anti-Glucosaminidase Monoclonal Antibodies as a Passive Immunization for Methicillin-Resistant Staphylococcus aureus (MRSA) Orthopaedic Infections. , 2011, BoneKEy osteovision.

[139]  V. Gant,et al.  Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? , 2011, Nature Reviews Microbiology.

[140]  J. V. van Dijl,et al.  A multiplex assay for the quantification of antibody responses in Staphylococcus aureus infections in mice. , 2011, Journal of immunological methods.

[141]  W. Kelley,et al.  Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus , 2011, EMBO molecular medicine.

[142]  Christina L. Jacovides,et al.  The Mark Coventry Award: Diagnosis of Early Postoperative TKA Infection Using Synovial Fluid Analysis , 2011, Clinical orthopaedics and related research.

[143]  Heikki Peltola,et al.  Short- Versus Long-term Antimicrobial Treatment for Acute Hematogenous Osteomyelitis of Childhood: Prospective, Randomized Trial on 131 Culture-positive Cases , 2010, The Pediatric infectious disease journal.

[144]  E. Walsh,et al.  Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. , 2010, The Journal of infectious diseases.

[145]  Alexander M Seifalian,et al.  Nanosilver as a new generation of nanoproduct in biomedical applications. , 2010, Trends in biotechnology.

[146]  D. Viemann,et al.  Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. , 2010, The Journal of infectious diseases.

[147]  G. Schmidmaier,et al.  Gentamycin delivered from a PDLLA coating of metallic implants: In vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. , 2010, Injury.

[148]  H. Flemming,et al.  The biofilm matrix , 2010, Nature Reviews Microbiology.

[149]  W. Liu,et al.  Impact of silver nanoparticles on human cells: Effect of particle size , 2010, Nanotoxicology.

[150]  A. Hofman,et al.  Induction of antibodies by Staphylococcus aureus nasal colonization in young children. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[151]  D. Missiakas,et al.  Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity , 2010, PLoS pathogens.

[152]  Myron Spector,et al.  The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. , 2010, Biomaterials.

[153]  David C Aron,et al.  Adherence to surgical care improvement project measures and the association with postoperative infections. , 2010, JAMA.

[154]  C. Mathers,et al.  Global, regional, and national causes of child mortality in 2008: a systematic analysis , 2010, The Lancet.

[155]  J. Potts,et al.  Staphylococcus aureus Host Cell Invasion and Virulence in Sepsis Is Facilitated by the Multiple Repeats within FnBPA , 2010, PLoS pathogens.

[156]  M. Raschke,et al.  Limb salvage or amputation? The use of a gentamicin coated nail in a severe, grade IIIc tibia fracture , 2010, European Journal of Trauma and Emergency Surgery.

[157]  M. Balke,et al.  Reduction of periprosthetic infection with silver‐coated megaprostheses in patients with bone sarcoma , 2010, Journal of surgical oncology.

[158]  W. Obremskey,et al.  Maintenance of hardware after early postoperative infection following fracture internal fixation. , 2010, The Journal of bone and joint surgery. American volume.

[159]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[160]  A. van Belkum,et al.  Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[161]  G. Moeck,et al.  Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis. , 2010, Bioorganic & medicinal chemistry letters.

[162]  B. Bröker,et al.  Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response. , 2010, International journal of medical microbiology : IJMM.

[163]  D. Missiakas,et al.  Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[164]  S. Engelmann,et al.  Human Immune Proteome in Experimental Colonization with Staphylococcus aureus , 2009, Clinical and Vaccine Immunology.

[165]  J. Yi,et al.  Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[166]  F. Lowy.  Staphylococcus aureus infections. , 2009, The New England journal of medicine.

[167]  J. Meehan,et al.  Local antibiotic therapy in osteomyelitis. , 2009, Seminars in plastic surgery.

[168]  C. Pineda,et al.  Radiographic imaging in osteomyelitis: the role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging, and scintigraphy. , 2009, Seminars in plastic surgery.

[169]  G. Lewis.  Properties of antibiotic-loaded acrylic bone cements for use in cemented arthroplasties: a state-of-the-art review. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[170]  G. Fischer,et al.  Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Infections, in Very-Low-Birth-Weight Neonates , 2009, Antimicrobial Agents and Chemotherapy.

[171]  J. Hahn,et al.  Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity. , 2009, Water research.

[172]  J. Parvizi,et al.  Outcome of a Second Two-stage Reimplantation for Periprosthetic Knee Infection , 2009, Clinical orthopaedics and related research.

[173]  W. Kelley,et al.  Staphylococcus aureus: new evidence for intracellular persistence. , 2009, Trends in microbiology.

[174]  J. Kelm,et al.  Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo , 2009, Acta orthopaedica.

[175]  W. Dhert,et al.  In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. , 2008, The Journal of arthroplasty.

[176]  Hugo Poirier,et al.  Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis. , 2008, Journal of medicinal chemistry.

[177]  S. Kurtz,et al.  Infection burden for hip and knee arthroplasty in the United States. , 2008, The Journal of arthroplasty.

[178]  F. Miller,et al.  Antibiotic-Loaded Allograft Decreases the Rate of Acute Deep Wound Infection After Spinal Fusion in Cerebral Palsy , 2008, Spine.

[179]  J. Parvizi,et al.  Periprosthetic Joint Infection: The Incidence, Timing, and Predisposing Factors , 2008, Clinical orthopaedics and related research.

[180]  Blaise R. Boles,et al.  agr-Mediated Dispersal of Staphylococcus aureus Biofilms , 2008, PLoS pathogens.

[181]  Cato T. Laurencin,et al.  Nanofibers and nanoparticles for orthopaedic surgery applications. , 2008, The Journal of bone and joint surgery. American volume.

[182]  E. Schwarz,et al.  Quantitative mouse model of implant‐associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[183]  K. Schlegel,et al.  Antibiotic-containing collagen for the treatment of bone defects. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[184]  J. Ong,et al.  Antibacterial and osteogenic properties of silver-containing hydroxyapatite coatings produced using a sol gel process. , 2007, Journal of biomedical materials research. Part A.

[185]  T. Muir,et al.  Molecular Mechanisms of agr Quorum Sensing in Virulent Staphylococci , 2007, Chembiochem : a European journal of chemical biology.

[186]  M. Hemmady,et al.  Recurrence of chronic osteomyelitis in a regenerated fibula after 65 years. , 2007, Orthopedics.

[187]  L. Klenerman.  A history of osteomyelitis from the Journal of Bone and Joint Surgery: 1948 TO 2006. , 2007, The Journal of bone and joint surgery. British volume.

[188]  H. Uludaǧ,et al.  'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. , 2007, Chemical Society reviews.

[189]  A. Hanssen,et al.  Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. , 2006, The Journal of bone and joint surgery. American volume.

[190]  Y. Liu,et al.  In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. , 2006, Biomaterials.

[191]  W. Zimmerli,et al.  Staphylococcus aureus small colony variants in prosthetic joint infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[192]  Y. Tabak,et al.  Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database* , 2006, Critical care medicine.

[193]  W. V. van Wamel,et al.  Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus , 2006, Cellular microbiology.

[194]  D. Patel,et al.  The Effect of Demineralized Bone Matrix-Calcium Sulfate with Vancomycin on Calcaneal Fracture Healing and Infection Rates: A Prospective Study , 2006, Foot & ankle international.

[195]  B. Masri,et al.  The management of peri-prosthetic infection in total joint arthroplasty. , 2006, The Journal of bone and joint surgery. British volume.

[196]  L. Webb,et al.  Intracellular Staphylococcus aureus and antibiotic resistance: Implications for treatment of staphylococcal osteomyelitis , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[197]  J. Schlager,et al.  In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[198]  T. Foster.  Immune evasion by staphylococci , 2005, Nature Reviews Microbiology.

[199]  C. R. Arciola,et al.  Etiology of Implant Orthopedic Infections: A Survey on 1027 Clinical Isolates , 2005, The International journal of artificial organs.

[200]  Keita Hara,et al.  Bactericidal Actions of a Silver Ion Solution on Escherichia coli, Studied by Energy-Filtering Transmission Electron Microscopy and Proteomic Analysis , 2005, Applied and Environmental Microbiology.

[201]  P. François,et al.  Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. , 2005, The Journal of infectious diseases.

[202]  M. Bosse,et al.  Internalization of bacteria by osteoblasts in a patient with recurrent, long-term osteomyelitis. A case report. , 2005, The Journal of bone and joint surgery. American volume.

[203]  D. Talan,et al.  Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections , 2005, Emerging infectious diseases.

[204]  William R Bishai,et al.  Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. , 2005, The Lancet. Infectious diseases.

[205]  B. Kocsis,et al.  Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients , 2005, Clinical Diagnostic Laboratory Immunology.

[206]  W. Zimmerli,et al.  Prosthetic-joint infections. , 2004, The New England journal of medicine.

[207]  J. Calhoun,et al.  Osteomyelitis in long bones. , 2004, The Journal of bone and joint surgery. American volume.

[208]  Michael Wagener,et al.  An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. , 2004, Biomaterials.

[209]  A. Hanssen.  Prophylactic use of antibiotic bone cement: an emerging standard--in opposition. , 2004, The Journal of arthroplasty.

[210]  G. Young,et al.  Myoclonic status epilepticus following repeated oral ingestion of colloidal silver , 2004, Neurology.

[211]  R. Darouiche.  Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.

[212]  G. Eyrich,et al.  Is primary chronic osteomyelitis a uniform disease? Proposal of a classification based on a retrospective analysis of patients treated in the past 30 years. , 2004, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[213]  Paul Stoodley,et al.  Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.

[214]  K. Mulhall,et al.  Adhesion of Staphylococcus to orthopaedic metals, an in vivo study , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[215]  Julia M. Ross,et al.  Characterization of a Protective Monoclonal AntibodyRecognizing Staphylococcus aureus MSCRAMM ProteinClumping FactorA , 2003, Infection and Immunity.

[216]  J. Mader,et al.  A Clinical Staging System for Adult Osteomyelitis , 2003, Clinical orthopaedics and related research.

[217]  Thomas L. Smith,et al.  Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis. , 2003, The Journal of bone and joint surgery. British volume.

[218]  N. Haas,et al.  Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. , 2003, Bone.

[219]  P. Herczegh,et al.  Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials. , 2002, Journal of medicinal chemistry.

[220]  K. Bost,et al.  Involvement of Mitogen-Activated Protein Kinase Pathways in Staphylococcus aureus Invasion of Normal Osteoblasts , 2001, Infection and Immunity.

[221]  Alexander Eh,et al.  Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. , 2001 .

[222]  K. Sayasith,et al.  Demonstration of intracellular Staphylococcus aureus in bovine mastitis alveolar cells and macrophages isolated from naturally infected cow milk. , 2000, FEMS microbiology letters.

[223]  F. Lowy.  Is Staphylococcus aureus an intracellular pathogen? , 2000, Trends in microbiology.

[224]  H. Busscher,et al.  Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation , 2000, Acta orthopaedica Scandinavica.

[225]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[226]  B. Masri,et al.  The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. , 1999, The Journal of arthroplasty.

[227]  Walenkamp Gh,et al.  Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. , 1998 .

[228]  B. Morrey,et al.  Treatment of Infection with Débridement and Retention of the Components following Hip Arthroplasty* , 1998, The Journal of bone and joint surgery. American volume.

[229]  P E Ochsner,et al.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.

[230]  A. van Belkum,et al.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks , 1997, Clinical microbiology reviews.

[231]  J. Zuckerman,et al.  The Reliability of Analysis of Intraoperative Frozen Sections for Identifying Active Infection during Revision Hip or Knee Arthroplasty*† , 1996, The Journal of bone and joint surgery. American volume.

[232]  R. Gustilo,et al.  Infection after Total Hip Arthroplasty. A Study of the Treatment of One Hundred and Six Infections* , 1996, The Journal of bone and joint surgery. American volume.

[233]  A. Tencer,et al.  Controlled release of antibiotics from coated orthopedic implants. , 1996, Journal of biomedical materials research.

[234]  J. Zuckerman,et al.  The role of intraoperative frozen sections in revision total joint arthroplasty. , 1995, The Journal of bone and joint surgery. American volume.

[235]  Y. An,et al.  Rapid quantification of staphylococci adhered to titanium surfaces using image analyzed epifluorescence microscopy , 1995 .

[236]  M. Smeltzer,et al.  Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis , 1995, Infection and immunity.

[237]  K. Calligaro.  Infections associated with indwelling medical devices , 1995 .

[238]  R. Letsch,et al.  [Local antibiotic administration in osteomyelitis treatment--a comparative study with two different carrier substances]. , 1993, Aktuelle Traumatologie.

[239]  F. Langlais,et al.  Release of Gentamicin from Acrylic Bone Cement , 1989, Clinical pharmacokinetics.

[240]  K. Julshamn,et al.  NEUROPATHY CAUSED BY SILVER ABSORPTION FROM ARTHROPLASTY CEMENT , 1985, The Lancet.

[241]  R. Elson,et al.  Antibiotic-loaded acrylic cement: current concepts. , 1984, Clinical orthopaedics and related research.

[242]  L. Lidgren,et al.  Total hip joint arthroplasty with gentamicin-impregnated cement. A clinical study of gentamicin excretion kinetics. , 1983, Clinical orthopaedics and related research.

[243]  W. Zimmerli,et al.  Pathogenesis of foreign body infection: description and characteristics of an animal model. , 1982, The Journal of infectious diseases.

[244]  P. Kelly,et al.  The depot administration of penicillin G and gentamicin in acrylic bone cement. , 1981, The Journal of bone and joint surgery. American volume.

[245]  F. Waldvogel,et al.  Osteomyelitis , 2004, The Lancet.

[246]  R. Sutherland,et al.  Antibacterial activity of antibiotics in acrylic bone cement. , 1977, The Journal of bone and joint surgery. British volume.

[247]  M. Swartz,et al.  Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects (second of three parts). , 1970, The New England journal of medicine.

[248]  M. Swartz,et al.  Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. , 1970, The New England journal of medicine.

[249]  S. D. Elek.  EXPERIMENTAL STAPHYLOCOCCAL INFECTIONS IN THE SKIN OF MAN , 1956, Annals of the New York Academy of Sciences.

[250]  W. E. Gallie.  First recurrence of osteomyelitis eighty years after infection. , 1951, The Journal of bone and joint surgery. British volume.

[251]  Eric B. Smith,et al.  General Assembly, Prevention, Operating Room - Surgical Technique: Proceedings of International Consensus on Orthopedic Infections. , 2019, The Journal of arthroplasty.

[252]  E. Schwarz,et al.  Chronic Osteomyelitis with Staphylococcus aureus Deformation in Submicron Canaliculi of Osteocytes: A Case Report , 2018, JBJS case connector.

[253]  E. Schwarz,et al.  Chapter 16 – The Role of the Immune System and Bone Cells in Acute and Chronic Osteomyelitis , 2016 .

[254]  Cis-2-Decenoic Acid Interacts with Bacterial Cell Membranes to Potentiate Additive and Synergistic Responses against Biofilm , 2016 .

[255]  Girbe Buist,et al.  A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia. , 2015, International journal of medical microbiology : IJMM.

[256]  Herren Wu,et al.  1 Mechanisms of Neutralization of a Human Anti-Alpha Toxin Antibody , 2014 .

[257]  S. Kaplan.  Recent lessons for the management of bone and joint infections. , 2014, The Journal of infection.

[258]  A. Hanssen,et al.  Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[259]  M. Otto.  Targeted Immunotherapy for Staphylococcal Infections , 2012, BioDrugs.

[260]  E. Schwarz,et al.  The Role of the Immune System and Bone Cells in Acute and Chronic Osteomyelitis , 2011 .

[261]  A. van Belkum,et al.  Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[262]  J. Anguita,et al.  TRAIL expression is induced in both osteoblasts containing intracellular Staphylococcus aureus and uninfected osteoblasts in infected cultures. , 2008, FEMS microbiology letters.

[263]  L. Webb,et al.  Osteomyelitis and intraosteoblastic Staphylococcus aureus. , 2007, Journal of Surgical Orthopaedic Advances.

[264]  M. O'Reilly,et al.  Regulation of exoprotein gene expression in Staphylococcus aureus by agr , 2004, Molecular and General Genetics MGG.

[265]  M. Hudson,et al.  Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans , 2001, Applied Microbiology and Biotechnology.

[266]  G. O’Toole,et al.  Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.

[267]  J. Kellam,et al.  In vivo internalization of Staphylococcus aureus by embryonic chick osteoblasts. , 2000, Bone.

[268]  D. Osmon,et al.  Prosthetic Joint Infections , 2000 .

[269]  STATUS OF IN , 2000 .

[270]  F. Langlais,et al.  Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement , 1998, International Orthopaedics.

[271]  Y. Nishimoto,et al.  Antibiotic-loaded porous hydroxyapatite blocks for the treatment of osteomyelitis and postoperative infection. A preliminary report. , 1998, Bulletin (Hospital for Joint Diseases (New York, N.Y.)).

[272]  G. Walenkamp,et al.  Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. , 1998, Acta orthopaedica Scandinavica.

[273]  D. Crook,et al.  Diagnosis of infection by frozen section during revision arthroplasty. , 1995, The Journal of bone and joint surgery. British volume.

[274]  E. Sudmann,et al.  Systemic and local silver accumulation after total hip replacement using silver-impregnated bone cement. , 1994, Medical progress through technology.

[275]  M. Höök,et al.  MSCRAMM-mediated adherence of microorganisms to host tissues. , 1994, Annual review of microbiology.

[276]  Charles P. Gerba,et al.  The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses , 1988 .

[277]  J W Costerton,et al.  How bacteria stick. , 1978, Scientific American.

[278]  B. Brodie.  Pathological Researches respecting the Diseases of Joints. , 1813, Medico-chirurgical transactions.

[279]  Brodie Bc.  Pathological Researches respecting the Diseases of Joints. , 1813 .